Mission BioCapital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
139
- Portfolio
-
72
- Exits
-
42
Mission BioCapital General Information
Company Description
Founded in 2009, Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts. The firm seeks to invest in early-stage companies. The firm seeks to invest in the life sciences and biotechnology sectors. This firm is an Exempt Reporting Adviser (ERA)
Business Details
Website
www.missionbiocapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- One Main Street
- Suite 1100
- Cambridge, MA 02142
- United States
Mission BioCapital Investments (139)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Oyster Therapeutics | 10-Nov-2026 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Dren Bio | 29-Oct-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Breye Therapeutics | 29-Sep-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Cloverleaf Bio | 08-Sep-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Enodia Therapeutics | 08-Jan-2026 | Biotechnology | Startup | |||
| Nocion Therapeutics | 07-Jan-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| AI Proteins | 12-Nov-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Seen Therapeutics | 01-Nov-2025 | Drug Discovery | Startup | |||
| EpiBiologics | 31-Oct-2025 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Zag Bio | 25-Oct-2025 | Early Stage VC | Drug Delivery | Startup |
Mission BioCapital Exits (42)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Dren Bio | 29-Oct-2026 | Later Stage VC | |
| State 4 Therapeutics | 26-May-2026 | ||
| Wildtype | 01-Apr-2026 | ||
| Avvio Medical | 01-Jan-2026 | ||
| ViThera Pharmaceuticals | 30-Nov-2025 | ||
| Sentien (Drug Discovery) | 29-Sep-2025 | ||
| Photoswitch Biosciences | 23-Aug-2025 | ||
| SiteOne Therapeutics | 28-Jul-2025 | ||
| Bolt Projects Holdings | 13-Aug-2024 | Reverse Merger | |
| Mitokinin | 04-Oct-2023 | Merger/Acquisition |
Mission BioCapital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Mission BioCapital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Mission BioCapital Co-Investors (208)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 5 |
|
|
||
| Mass General Brigham Ventures |
|
|
|||
| Pfizer Ventures |
|
|
|||
| Novo Holdings |
|
|
|||
| Polaris Partners |
|
|
Mission BioCapital FAQs
-
What is Mission BioCapital?
Founded in 2009, Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts.
-
When was Mission BioCapital founded?
Mission BioCapital was founded in 2009.
-
Where is Mission BioCapital headquartered?
Mission BioCapital is headquartered in Cambridge, MA.
-
What is Mission BioCapital's total asset value?
Mission BioCapital has around in total assets under management.
-
How many investments has Mission BioCapital made?
Mission BioCapital has made 139 investments.
-
What has Mission BioCapital invested in?
Mission BioCapital has made numerous investments in companies like Oyster Therapeutics, Dren Bio, and Breye Therapeutics within the Drug Discovery industry.
-
What has Mission BioCapital invested in recently?
Mission BioCapital's latest investment was on 10-Nov-2026 in Oyster Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
